Applying Sensor-Based Glucose Monitoring (CGM) to Reduce Cost-Intensive, Adverse Drug Events Associated with Diabetes Treatment - Eric Cannon, PharmD

Applying Sensor-Based Glucose Monitoring (CGM) to Reduce Cost-Intensive, Adverse Drug Events Associated with Diabetes Treatment - Eric Cannon, PharmD


Published

April 9, 2021

Created by

CMEducation Resources symposium

Related Presenters

Eric Cannon, PharmD, FAMCP

Eric Cannon, PharmD, FAMCP

Chief Pharmacy Benefits Officer
SelectHealth
Salt Lake City, Utah